Hologic (NSDQ:HOLX) said its nearly $4 billion buyout of molecular diagnostics giant Gen-Probe (NSDQ:GPRO) is in the books, a day after Gen-Probe’s shareholders OK’d the $82.75-per-share deal.
Cardiosolutions Inc.
Cardiosolutions raises $3.3M | Funding Roundup
Cardiosolutions Inc. landed about half of what it hopes will amount to a $6.5 million fundraising round, pulling in $3.3 million from eight un-named investors, according to a regulatory filing.
The Stoughton, Mass.-based company is a spinout from contract manufacturer STD Med, which early last year bought a new, 32,000-square-foot cleanroom to house Cardiosolutions and sister firm Spirus Medical Inc.
Medical device makers drum up $2.5 million in December equity, debt sales
Five medical device makers based in New England together raised more than $2.5 million in debt and equity sales, according to filings with the Securities and Exchange Commission.
BioBehavioral Diagnostics Co., Cardiosolutions Inc., Echo Therapeutics Inc., Eleme Medical Inc. and Myomo Inc. all sold debt or equity for an average net return of about $500,000 last month:
